Last updated on June 2020

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis


Brief description of study

The purpose of this study is to evaluate the clinical efficacy and safety of combination therapy with guselkumab and golimumab in participants with moderately to severely active ulcerative colitis (UC).

Clinical Study Identifier: NCT03662542

Find a site near you

Start Over

St Vincent's hospital

Darlinghurst, Australia
  Connect »

Concord Hospital

Concord, Australia
7.85miles
  Connect »

Macquarie University Hospital

New South Wales, Australia
9.49miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.